Family Medicine Doctors in Estes Park, CO Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Dr. Bridget Ann Dunn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Prospect Ave, Suite 300, Estes Park, CO 80517 Phone: 970-586-2200    Fax: 970-577-4536

Dr. Bruce Alan Woolman, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 131 Stanley Avenue, Suite 202, Estes Park, CO 80517 Phone: 970-586-2343    Fax: 970-586-9060

Dr. Michael Brian Rountree, M.D. Family Medicine - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Far View Dr, Estes Park, CO 80517 Phone: 828-719-0026

Dr. John Kevin Stanton, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1950 Redtail Hawk Dr, Estes Park, CO 80517 Phone: 970-586-9230    Fax: 970-586-0292

Mr. Guy P Van Der Werf, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Stanley Ave Ste 202, Estes Park, CO 80517 Phone: 970-586-2344    Fax: 970-586-9060

Robyn A Zehr, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Prospect Ave, Estes Park, CO 80517 Phone: 970-586-2200    Fax: 970-577-4536

Dr. Paul W Fonken, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Stanley Ave, Suite 202, Estes Park, CO 80517 Phone: 970-586-2343    Fax: 970-586-9060

Dr. Erika Jane Norris, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Stanley Ave, Suite 202, Estes Park, CO 80517 Phone: 970-586-2343    Fax: 970-586-9060

Paige Dekker, D.O Family Medicine Medicare: Medicare Enrolled Practice Location: 555 Prospect Ave, Estes Park, CO 80517 Phone: 970-586-2317

News Archive

FDA approval paves way for U-M to conduct Phase II trial of stem cell injections in ALS patients

For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.

Intervention program reduces asthma in children

An asthma intervention program applied during the first year of life significantly reduced the prevalence of asthma in high risk children at 7 years of age, according to a new study featured on the online version of the Journal of Allergy & Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

Mallinckrodt announces commercial launch of PENNSAID

Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.

Zinc key to formation of hospital-acquired infections

Hospital-acquired infections that are resistant to traditional antibiotic treatment have become increasingly common in recent years, confounding health care professionals and killing thousands of Americans.

Read more Medical News

› Verified 8 days ago